创金合信全球医药生物股票发起(QDII)C

(018156)公募QDII
重仓股明细
查询指定年度的基金持仓:
季报日期:  2026-03-31
序号 股票代码 股票名称 占净值比例 持股数量(万股) 持股市值(万元) 占股票市值比例(季报) 持仓变动
1 EWTX Edgewise Therapeutics Inc 4.59% 6.21 1352.91 5.29% -17.65 (-284.43%)
2 SMMT Summit Therapeutics Inc 4.52% 10.15 1331.61 5.20% 5.60 (55.17%)
3 ANAB AnaptysBio Inc 3.97% 3.05 1168.56 4.57% -6.44 (-211.48%)
4 CELC Celcuity LLC 3.46% 1.29 1017.71 3.98% 0.03 (1.96%)
5 PTGX Protagonist Therapeutics Inc 3.27% 1.32 963.12 3.76% -2.23 (-168.61%)
6 BNTX BioNTech SE ADR 3.17% 1.52 934.43 3.65% 新增
7 NKTR 内克塔治疗 3.17% 1.88 935.16 3.66% -5.56 (-295.80%)
8 NAMS NewAmsterdam Pharma Co NV 3.14% 4.17 923.79 3.61% 1.22 (29.21%)
9 COGT Cogent Biosciences Inc 2.86% 3.16 840.98 3.29% -4.00 (-126.75%)
10 ABVX Abivax SA ADR 2.54% 0.97 748.90 2.93% -0.39 (-40.05%)
显示全部持仓明细>>